Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Poly(ADP-ribose) polymerase can bind melphalan damaged DNA

J Bramson1, J Prévost, A Malapetsa

  • 1Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada.

Cancer Research
|November 15, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal of medical economics·2023
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022
Same author

Altered Levels of Salivary 8-oxo-7-hydrodeoxyguanosine in Breast Cancer.

JDR clinical and translational research·2019
Same author

The Canadian Institutes of Health Research response to antimicrobial resistance.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
Same author

A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.

Breast cancer research and treatment·2017
Same author

The von Hippel-Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform.

British journal of cancer·2015

Poly(ADP-ribose) polymerase is identified as the sole protein in chronic lymphocytic leukemia cells that binds to melphalan-damaged DNA. This finding is crucial for understanding DNA repair mechanisms in cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Chronic lymphocytic leukemia (CLL) involves DNA damage.
  • Identifying proteins involved in DNA repair is critical for understanding CLL pathogenesis.
  • Nitrogen mustards are alkylating agents that cause DNA lesions.

Purpose of the Study:

  • To identify proteins that recognize DNA damage caused by melphalan, a nitrogen mustard analogue.
  • To investigate the role of these proteins in DNA repair in chronic lymphocytic leukemia cells.

Main Methods:

  • Southwestern analysis was performed using a melphalan-damaged DNA probe and protein extracts from CLL patients.
  • Proteins binding to the damaged probe were detected and characterized by molecular weight.
  • Methoxyamine was used to inhibit DNA strand breakage, and poly(ADP-ribose) polymerase was depleted from extracts to assess binding specificity.

Related Experiment Videos

Main Results:

  • Proteins with molecular weights of 116,000, 66,000, and 64,000 Da were found to bind the damaged probe.
  • The 66,000 and 64,000 Da proteins were identified as degradation products of the 116,000 Da protein.
  • The 116,000 Da protein was identified as poly(ADP-ribose) polymerase (PARP).
  • Methoxyamine treatment reduced PARP binding to the damaged probe.
  • Depletion of PARP abolished all detectable binding activity.

Conclusions:

  • Poly(ADP-ribose) polymerase is the primary protein in chronic lymphocytic leukemia cells that binds to melphalan-damaged DNA.
  • PARP plays a significant role in recognizing and potentially repairing DNA lesions caused by melphalan.
  • These findings contribute to understanding DNA damage response pathways in CLL.